High‐Precision Measurement of Hydrogen Bond Lengths in Proteins by Nuclear Magnetic Resonance Methods
暂无分享,去创建一个
[1] R. Shulman,et al. High resolution nuclear magnetic resonance study of the histidine--aspartate hydrogen bond in chymotrypsin and chymotrypsinogen. , 1972, Journal of molecular biology.
[2] D. Metzler,et al. NMR observation of exchangeable protons of pyridoxal phosphate and histidine residues in cytosolic aspartate aminotransferase. , 1991, The Journal of biological chemistry.
[3] W. Saenger,et al. Lengthening of the covalent O–H bond in O–H⋯O hydrogen bonds re-examined from low-temperature neutron diffraction data of organic compounds , 1994 .
[4] W. Cleland. Low-barrier hydrogen bonds and enzymatic catalysis. , 2000, Archives of biochemistry and biophysics.
[5] M Karplus,et al. Structure of the triosephosphate isomerase-phosphoglycolohydroxamate complex: an analogue of the intermediate on the reaction pathway. , 1991, Biochemistry.
[6] A. Tulinsky,et al. Structure of a tetrahedral transition state complex of alpha-chymotrypsin dimer at 1.8-A resolution. , 1987, The Journal of biological chemistry.
[7] A. Mildvan,et al. Studies of the catalytic mechanism of an active-site mutant (Y14F) of delta 5-3-ketosteroid isomerase by kinetic deuterium isotope effects. , 1991, Biochemistry.
[8] M. M. Kreevoy. The exposition of isotope effects on rates and equilibria , 1964 .
[9] A. Warshel,et al. Energy considerations show that low-barrier hydrogen bonds do not offer a catalytic advantage over ordinary hydrogen bonds. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Frey,et al. A low-barrier hydrogen bond in the catalytic triad of serine proteases. , 1994, Science.
[11] R. Schowen,et al. [29] Solvent isotope effects on enzyme systems , 1982 .
[12] G. Petsko,et al. Triosephosphate isomerase: removal of a putatively electrophilic histidine residue results in a subtle change in catalytic mechanism. , 1988, Biochemistry.
[13] J. Markley,et al. Hydrogen bonding in proteins as studied by amide hydrogen D/H fractionation factors: application to staphylococcal nuclease. , 1994, Biochemistry.
[14] A. Mildvan,et al. Hydrogen Bonding at the Active Site of Δ5-3-Ketosteroid Isomerase† , 1997 .
[15] G. Robillard,et al. High resolution nuclear magnetic resonance studies of the active site of chymotrypsin. I. The hydrogen bonded protons of the "charge relay" system. , 1974, Journal of molecular biology.
[16] R. Huber,et al. Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. , 1985, Journal of molecular biology.
[17] T. Harris,et al. NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase. , 1997, Biochemistry.
[18] Michael A. McAllister,et al. Characterization of Low-Barrier Hydrogen Bonds. 5. Microsolvation of Enol-Enolate. An ab Initio and DFT Investigation. , 1997, The Journal of organic chemistry.
[19] D. Shortle,et al. Kinetic and ultraviolet spectroscopic studies of active-site mutants of delta 5-3-ketosteroid isomerase. , 1989, Biochemistry.
[20] A. Pardi,et al. Hydrogen bond length and proton NMR chemical shifts in proteins , 1983 .
[21] T. Liang,et al. Complex of alpha-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy. , 1987, Biochemistry.
[22] D. Blow,et al. Structure of α-chymotrypsin refined at 1.68 Å resolution☆ , 1985 .
[23] D. Herschlag,et al. The change in hydrogen bond strength accompanying charge rearrangement: implications for enzymatic catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] L. Pauling,et al. Structural chemistry and molecular biology , 1968 .
[25] R. Schowen,et al. Solvent isotope effects of enzyme systems. , 1982, Methods in Enzymology.
[26] P. Frey,et al. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Bax,et al. Equilibrium Protium/Deuterium Fractionation of Backbone Amides in U−13C/15N Labeled Human Ubiquitin by Triple Resonance NMR , 1996 .
[28] P A Frey,et al. The Low Barrier Hydrogen Bond in Enzymatic Catalysis* , 1998, The Journal of Biological Chemistry.
[29] B. Oh,et al. High-resolution crystal structures of delta5-3-ketosteroid isomerase with and without a reaction intermediate analogue. , 1997, Biochemistry.
[30] W. M. Westler,et al. Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A. , 1996, Biochemistry.
[31] Calculation of the Potential Energy Surface for Intermolecular Amide Hydrogen Bonds Using Semiempirical and Ab Initio Methods , 1996 .
[32] A. Bax,et al. Solution NMR characterization of hydrogen bonds in a protein by indirect measurement of deuterium quadrupole couplings. , 1997, Journal of magnetic resonance.
[33] A. Mildvan,et al. NMR evidence for the participation of a low-barrier hydrogen bond in the mechanism of delta 5-3-ketosteroid isomerase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Scheiner,et al. The Nonexistence of Specially Stabilized Hydrogen Bonds in Enzymes , 1995 .
[35] Michael A. McAllister,et al. CHARACTERIZATION OF LOW-BARRIER HYDROGEN BONDS. 7. RELATIONSHIP BETWEEN STRENGTH AND GEOMETRY OF SHORT-STRONG HYDROGEN BONDS. THE FORMIC ACID-FORMATE ANION MODEL SYSTEM. AN AB INITIO AND DFT INVESTIGATION , 1997 .
[36] W. Cleland,et al. Low-barrier hydrogen bonds and enzymic catalysis. , 1994, Science.
[37] P. Frey,et al. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. , 1997, Biochemistry.
[38] J. Emsley,et al. Hydrogen Bonding and Chemical Reactivity , 1991 .
[39] W. Huskey,et al. Hydrogen Bonding to Active-Site Histidine in Peptidyl Boronic Acid Inhibitor Complexes of Chymotrypsin and Subtilisin: Proton Magnetic Resonance Assignments and H/D Fractionation , 1999 .
[40] Grace Jordison. Molecular Biology of the Gene , 1965, The Yale Journal of Biology and Medicine.
[41] V. Stoll,et al. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes. , 1998, Biochemistry.
[42] J. Guthrie. Short strong hydrogen bonds: can they explain enzymic catalysis? , 1996, Chemistry & biology.
[43] J. Wells,et al. Dissecting the catalytic triad of a serine protease , 1988, Nature.
[44] J. Markley,et al. Zymogen activation in serine proteinases. Proton magnetic resonance pH titration studies of the two histidines of bovine chymotrypsinogen A and chymotrypsin Aalpha. , 1978, Biochemistry.
[45] P. Kuhn,et al. The 0.78 A structure of a serine protease: Bacillus lentus subtilisin. , 1998, Biochemistry.
[46] D. Ringe,et al. Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. , 1990, Biochemistry.
[47] A. Mildvan,et al. Combined effects of two mutations of catalytic residues on the ketosteroid isomerase reaction. , 1990, Biochemistry.
[48] I. Miyahara,et al. Use of 1H-15N heteronuclear multiple-quantum coherence NMR spectroscopy to study the active site of aspartate aminotransferase. , 1997, Biochemistry.
[49] P A Kollman,et al. On low-barrier hydrogen bonds and enzyme catalysis. , 1995, Science.
[50] D. Blow,et al. Structure of alpha-chymotrypsin refined at 1.68 A resolution. , 1985, Journal of molecular biology.
[51] J. Knowles,et al. Triosephosphate isomerase: energetics of the reaction catalyzed by the yeast enzyme expressed in Escherichia coli. , 1988, Biochemistry.
[52] M. Massiah,et al. Solution structure of Delta 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate. , 1999, Biochemistry.
[53] P. Privalov,et al. Energetics of protein structure. , 1995, Advances in protein chemistry.
[54] R. Cole,et al. Proton transfer in the mechanism of triosephosphate isomerase. , 1998, Biochemistry.